UnitedHealth Group Inc
Change company Symbol lookup
Select an option...
UNH UnitedHealth Group Inc
BAC Bank of America Corp
WSO Watsco Inc
LITB LightInTheBox Holding Co Ltd
CVCY Central Valley Community Bancorp
AFAQU AF Acquisition Corp
HCIIW Hudson Executive Investment Equity II Warrant Exp 31 Jan 2027 *W EXP 01/31/2027
MEDS TRxADE Health Inc
HCICW Hennessy Capital Investment V Equity Warrant Exp 15 Jan 2025 *W EXP 01/15/2025
LSCC Lattice Semiconductor Corp

Health Care : Health Care Providers & Services | Large Cap Blend
Company profile

UnitedHealth Group Incorporated is a diversified health care company that operates Optum and UnitedHealthcare platforms. The Company’s segments include Optum Health, Optum Insight, Optum Rx and UnitedHealthcare. Optum Health provides health and wellness care, addressing the physical, emotional and health-related financial needs. Optum Health, through its national health care delivery platform, engages people in care settings, including clinical sites, in-home and virtual. Optum Insight serves the needs of health systems, such as physicians and hospital systems, health plans, state governments and life sciences companies. Optum Rx provides a range of pharmacy care services through retail pharmacies, specialty and community health pharmacies and provides in-home and community-based infusion services. UnitedHealthcare segment includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State and UnitedHealthcare Global.

Closing Price
Day's Change
3.31 (0.68%)
B/A Size
Day's High
Day's Low

10-day average volume:

IBM sheds Watson Health assets as it works to refocus its business

10:23 am ET January 21, 2022 (MarketWatch)

By Emily Bary

Analyst notes the 'likely limited success of this unit the past several years'

International Business Machines Corp. will sell assets from its Watson Health business to an investment firm as it continues to refocus its business.

IBM (IBM) and Francisco Partners announced Friday that the investment firm will purchase "extensive and diverse data sets and products" from IBM that are currently part of the Watson Health business. The companies expect the deal to close in the second quarter. Financial terms were not disclosed.

IBM shares are off 0.2% in Friday trading. They have gained 6.5% over the past three months, while the Dow Jones Industrial Average has lost 3.0%.

The Wall Street Journal reported in early 2021 that IBM was considering a sale of the Watson Health business, and a report from Axios earlier this year indicated that the company was still interested in a deal.

Subscribe: Want intel on all the news moving markets? Sign up for our daily Need to Know newsletter

The transaction isn't surprising, according to UBS analyst David Vogt, since key IBM executive and Watson proponent John Kelly retired from the company at the end of 2020.

"Moreover, we believe the market has been anticipating ongoing small changes to IBM's portfolio to divest businesses that do not neatly fit into its three new business segments," he wrote in a note to clients.

IBM sees the deal as a way to become "even more focused on our platform-based hybrid cloud and AI strategy," Tom Rosamilia, its senior vice president for IBM Software, said in a release.

Though the companies didn't disclose financial terms of the arrangement, Vogt doubted that it would materially impact IBM's financials "given the likely limited success of this unit the past several years."

He noted that, with Watson Health, IBM completed numerous acquisitions as it sought to disrupt the healthcare field by combining areas like patient records, medical literature, and medical imaging, and applying data analytics to the process.

IBM is due to report fourth-quarter earnings on Jan. 24.

-Emily Bary


(END) Dow Jones Newswires

January 21, 2022 10:23 ET (15:23 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.